# Antibiotic medicines: Use case

Source page: https://www.materialinsights.org/products/p_antibiotic_medicines/prod-use/

#### Use cases

Each use, its share of demand and volume, how critical the product is to it and why, and the price paid

| Use case | Volume | Unit | Criticality | Reason | Price | Price unit | Year | Source |
|---|---|---|---|---|---|---|---|---|
| Treating bacterial infections in people worldwide (use per 1,000 people per day, 2018) | 14.3 | defined daily doses per 1,000 people per day | Essential | Judgement: no practical substitute for treating serious bacterial infection; the GRAM study counts 1.14 million deaths attributable to bacterial antimicrobial resistance in 2021. | – | – | 2018 | ^[3]^[7] |
| Treating bacterial infections in low- and middle-income countries (2018 rate; up 76% from 2000) | 13.1 | defined daily doses per 1,000 people per day | Essential | Judgement: the rate rose 76% between 2000 and 2018 while high-income rates stayed stable. | – | – | 2018 | ^[3] |
| Treating bacterial infections in India's private sector | 5.07 billion | defined daily doses (10.4 per 1,000 people per day) | Essential | Judgement: antibiotics are sold on prescription in India and no substitute is named in the sources opened. | – | – | 2019 | ^[4] |
| Children's treatment bought through UNICEF (amoxicillin dispersible tablets; UNICEF's observed demand and procurement) | 320 million | tablets in 2017 | Important | Judgement: other antibiotics could be used, at a cost and with different resistance patterns. | 0.22 | US$ per course for a child under one year | 2017 | ^[10] |

as of 2026-11-14

#### Industries that buy it

The industries and kinds of firm that buy it, for which use case, and how critical it is to them
 Used by

- [Healthcare services](https://www.materialinsights.org/industries/healthcare/) Treatment of bacterial infections · criticality essential Clinics and hospitals prescribe antibiotics; in India they may be sold by retail only on a registered medical practitioner's prescription ^[17]. No share by setting was found.
- [Retail and online pharmacies](https://www.materialinsights.org/industries/healthcare/) Retail sale in India · criticality essential A press report on the Koya et al. study says the private sector accounts for 85 to 90% of India's antibiotic consumption ^[5]; the share sold by pharmacies was not found.

as of 2026-11-14

#### What it competes with

The products and technologies that compete with it in each use case
 Competes with

- [Vaccines](https://www.materialinsights.org/products/p_vaccines/) Preventing bacterial infections so that fewer antibiotics are needed Only a partial swap, for the infections that have a vaccine. WHO estimates that vaccines against 23 pathogens, including some still to be developed, could cut the antibiotics needed by 22%, or 2.5 billion defined daily doses a year ^[21]; no cost comparison was found.

as of 2026-11-14

#### How it is used

Lifetime, use per year and utilisation, by variant

| Measure | Value | Unit | Place | Year | Source |
|---|---|---|---|---|---|
| Antibiotic use, world average | 14.3 | defined daily doses per 1,000 people per day | World | 2018 | ^[3] |
| Antibiotic use, low- and middle-income countries | 13.1 | defined daily doses per 1,000 people per day | World | 2018 | ^[3] |
| Antibiotic use, private sector | 10.4 | defined daily doses per 1,000 people per day | India | 2019 | ^[4] |
| Share of that use in formulations not approved by the central regulator (as the study gives it; 2,408 of 5,071 million doses is 47.5% by calculation) | 47.1 | % of defined daily doses | India | 2019 | ^[4] |
| Share of that use in the single most used formulation, azithromycin 500 mg tablet (press report on the study) | 7.6 | % | India | 2019 | ^[5] |
| Highest national antibiotic use rate among countries in the 2000 to 2018 study (the lowest was 5.0) | 45.9 | defined daily doses per 1,000 people per day (highest country) | World | 2018 | ^[3] |

as of 2026-11-14

#### Prices

Unit prices by market or use, with year and source

| Market | Value | Unit | Year | Source |
|---|---|---|---|---|
| UNICEF indicative price per treatment course of amoxicillin dispersible tablets, child under one year | 0.22 | US$ per course | 2018 | ^[10] |
| UNICEF indicative price per treatment course of amoxicillin dispersible tablets, child over one year | 0.44 | US$ per course | 2018 | ^[10] |
| India, NPPA ceiling price of azithromycin 500 mg tablet (price control) | 11.67 | Rs per tablet | 2024 | ^[19] |
| United States, price of penicillin as production grew, July 1943 | 20 | US$ per dose | 1943 | ^[12] |
| United States, price of penicillin three years after July 1943 (year calculated) | 0.55 | US$ per dose | 1946 | ^[12] |

as of 2026-11-14

#### Sources

1. [Global antibiotic consumption rates increased by 46 percent since 2000](https://www.ox.ac.uk/news/2021-11-16-global-antibiotic-consumption-rates-increased-46-percent-2000) University of Oxford (news on Browne et al., Lancet Planetary Health), 2021, news item of 16 November 2021
2. [Consumption of systemic antibiotics in India in 2019 (Koya, Ganesh, Selvaraj, Wirtz, Galea, Rockers)](https://doaj.org/article/d212568d4b16440993b12db2d59c9350) The Lancet Regional Health - Southeast Asia, vol. 4, p. 100025 (record on DOAJ), 2022, abstract only
3. [Over 47 per cent antibiotic formulations used in India in 2019 unapproved: Lancet study](https://www.theprint.in/india/over-47-per-cent-antibiotic-formulations-used-in-india-in-2019-unapproved-lancet-study/1119365) ThePrint (PTI report on the Koya et al. study), 2022, 7 September 2022; secondhand press report
4. [Antibiotic resistance has claimed at least one million lives each year since 1990](https://www.ox.ac.uk/news/2024-09-17-antibiotic-resistance-has-claimed-least-one-million-lives-each-year-1990) University of Oxford (news on the GRAM study in The Lancet), 2024, news item of 17 September 2024 (date from the web address); GRAM study 'Global burden of bacterial antimicrobial resistance 1990 to 2021'
5. [Amoxicillin Dispersible Tablets: Market and Supply Update](https://www.unicef.org/supply/media/511/file/amoxicillin-dispersible-tablets-market-and-supply-update.pdf) UNICEF Supply Division, 2018, May 2018; Tables 1, 3 and 4
6. [Penicillin: Opening the Era of Antibiotics](https://www.ars.usda.gov/midwest-area/peoria-il/national-center-for-agricultural-utilization-research/docs/penicillin-opening-the-era-of-antibiotics/) US Department of Agriculture, Agricultural Research Service, 2024, page last modified 8 February 2024
7. [Rational Use Of Antibiotics For Limiting Antimicrobial Resistance: CDSCO lists down steps for Pharma cos, chemists and drug controllers](https://business.medicaldialogues.in/rational-use-of-antibiotics-for-limiting-antimicrobial-resistance-cdsco-lists-down-steps-for-pharma-cos-chemists-and-drug-controllers) Medical Dialogues, 2019, 26 December 2019, Medical Dialogues Bureau; secondhand report of a CDSCO notice
8. [NPPA Hikes Prices of Key Antibiotics Azithromycin, Amoxicillin Clavulanic Acid](https://medicaldialogues.in/news/industry/pharma/nppa-hikes-prices-of-key-antibiotics-azithromycin-amoxicillin-clavulanic-acid-143145) Medical Dialogues, 2025, 12 February 2025, by Farhat Nasim; reports the review order dated 4 October 2024
9. [Better use of vaccines could reduce antibiotic use by 2.5 billion doses annually, says WHO](https://www.who.int/news/item/10-10-2024-better-use-of-vaccines-could-reduce-antibiotic-use-by-2.5-billion-doses-annually--says-who) World Health Organization, 2024, 10 October 2024; corrected on 24 October 2024 to 23 pathogens

## Other sections

- [Summary](https://www.materialinsights.org/products/p_antibiotic_medicines/index.md)
- [Working](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-working/index.md)
- [Bill of materials](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-bom/index.md)
- [Supply chain](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-supply/index.md)
- [Footprint](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-footprint/index.md)
- [Evolution](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-evolution/index.md)
- [Interventions](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-interventions/index.md)
